The shares are now hovering at a premium of around ₹105-110 in the grey market— which is an upside of 7% over the issue price band. The shares of the recently concluded Gland Pharma IPO are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback